Skip to main content

Envisioning is an emerging technology research institute and advisory.

LinkedInInstagramGitHub

2011 — 2026

research
  • Reports
  • Newsletter
  • Methodology
  • Origins
  • Vocab
services
  • Research Sessions
  • Signals Workspace
  • Bespoke Projects
  • Use Cases
  • Signal Scanfree
  • Readinessfree
impact
  • ANBIMAFuture of Brazilian Capital Markets
  • IEEECharting the Energy Transition
  • Horizon 2045Future of Human and Planetary Security
  • WKOTechnology Scanning for Austria
audiences
  • Innovation
  • Strategy
  • Consultants
  • Foresight
  • Associations
  • Governments
resources
  • Pricing
  • Partners
  • How We Work
  • Data Visualization
  • Multi-Model Method
  • FAQ
  • Security & Privacy
about
  • Manifesto
  • Community
  • Events
  • Support
  • Contact
  • Login
ResearchServicesPricingPartnersAbout
ResearchServicesPricingPartnersAbout
  1. Home
  2. Research
  3. Horizons
  4. Microbiome Engineering

Microbiome Engineering

Designing and manipulating microbial communities to improve health, agriculture, and ecosystems
Back to HorizonsView interactive version

Microbiome engineering involves designing and manipulating communities of microorganisms—the complex ecosystems of bacteria, fungi, viruses, and other microbes that live in and on organisms or in environments—to achieve desired outcomes. The technology uses various approaches including selecting beneficial microbes, genetically engineering microorganisms, combining specific microbial strains into consortia, and modifying environmental conditions to favor desired microbial communities. The goal is to understand and control these complex ecosystems to improve health, agricultural productivity, environmental remediation, or other outcomes.

The technology addresses the growing understanding that microbiomes play crucial roles in health, agriculture, and ecosystems, and that manipulating these communities could provide powerful interventions. Engineered microbiomes could treat diseases by restoring healthy gut bacteria, improve crop yields by enhancing soil microbiomes, clean up pollution through microbial degradation, and enhance food production through fermentation. Applications include probiotics and microbiome-based therapies for human health, soil microbiome enhancement for agriculture, engineered microbes for bioremediation, and microbial consortia for industrial processes. Companies and research institutions are developing microbiome engineering approaches.

At TRL 5, microbiome engineering is being tested in various applications, though understanding and controlling complex microbial communities remains challenging. The technology faces obstacles including the complexity of microbial ecosystems and their interactions, ensuring engineered communities persist and function as intended, understanding long-term effects, and regulatory approval for engineered microbes. However, as understanding of microbiomes improves and genetic engineering capabilities advance, microbiome engineering becomes more feasible. The technology could transform medicine, agriculture, and environmental management by enabling precise control of microbial communities, potentially treating diseases, improving food production, and cleaning up pollution through engineered microbiomes, though it requires careful consideration of ecological impacts and long-term effects of manipulating these complex systems.

TRL
5/9Validated
Impact
3/5
Investment
3/5
Category
Hardware

Related Organizations

Eligo Bioscience logo
Eligo Bioscience

France · Startup

95%

A gene-editing company focused on the microbiome.

Developer
Ginkgo Bioworks logo
Ginkgo Bioworks

United States · Company

95%

A horizontal platform for cell programming that enables other companies to develop precision fermentation strains.

Developer
Pivot Bio logo
Pivot Bio

United States · Startup

95%

An agricultural tech company producing microbial nitrogen fertilizers.

Developer
Seres Therapeutics logo
Seres Therapeutics

United States · Company

95%

A commercial-stage microbiome therapeutics company.

Developer
Synlogic

United States · Company

95%

Develops Synthetic Biotic medicines.

Developer
BiomX logo
BiomX

Israel · Company

90%

A clinical-stage microbiome company developing natural and engineered phage therapies.

Developer
Indigo Ag logo
Indigo Ag

United States · Company

90%

Improves grower profitability and environmental sustainability using microbiology and digital technologies.

Developer
Vedanta Biosciences logo
Vedanta Biosciences

United States · Company

90%

Developing a new class of therapies for immune-mediated diseases based on defined bacterial consortia.

Developer
MaaT Pharma

France · Company

85%

Developing Microbiome Ecosystem Therapies (MET) dedicated to improving survival in cancer patients.

Developer
Novonesis logo

Novonesis

Denmark · Company

85%

The merger of Novozymes and Chr. Hansen, a global biosolutions giant supplying enzymes and microbes for fermentation.

Developer
Eagle Genomics

United Kingdom · Company

80%

Applies network science to biology to discover data-driven microbiome insights.

Developer

Supporting Evidence

Evidence data is not available for this technology yet.

Connections

Hardware
Hardware
Precision Fermentation

Engineered microbes producing proteins, fats, and ingredients through controlled fermentation

TRL
8/9
Impact
5/5
Investment
3/5
Hardware
Hardware
Genetic Reprogramming

Modifying gene expression to correct defects, silence genes, or transform cell types

TRL
4/9
Impact
5/5
Investment
5/5

Book a research session

Bring this signal into a focused decision sprint with analyst-led framing and synthesis.
Research Sessions